eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, announces a more than 40-percent annual license growth of its elluminate® Clinical Data Platform in 2020. This brings the total global adoption of elluminate to over 100 life sciences companies.
An end-to-end clinical data platform, elluminate is helping life sciences companies manage the increasing volume and diversity in clinical research including data streams from decentralized trials. By unifying diverse, disparate data sources into one centralized platform for real-time access, standardization and analysis, elluminate helps organizations maximize the value of their clinical data.
Over the last two years, a 40-percent increase in data cleaning cycle times, now back to the same number of days required for cleaning paper case report forms, has created a strong demand for more advanced technological solutions for managing clinical trial data. eClinical’s expanded clinical trial management software now includes elluminate Risk-Based Monitoring and elluminate Clinical Trial Management System (CTMS) based on customer needs for clinical trial operations automation. elluminate CTMS allows clinical operations teams working with outsourced partners and CROs to own their operational data for faster insights, trial oversight and operational excellence.
“Now is the time to solve the data problem in life sciences,” said Raj Indupuri, Co-Founder and CEO of eClinical Solutions. “The process of reviewing, standardizing and analyzing clinical data has not changed substantially in 25 years. With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments faster to the patients.”
To support increased adoption, the elluminate platform currently includes 20+ out-of-the-box connectors for enterprise interoperability with different software providers and is constantly expanding these capabilities. Recent growth in the elluminate partner network includes AG Mednet and Clinical Ink. “These partners allow for the seamless flow of more data sources into elluminate for ease of use and expansion of the elluminate ecosystem. We’re proud to work with life science leaders in technology, systems integrators, CROs and consulting who share our goal of improving clinical development through faster, data-driven processes,” said Bob Arnesen, eClinical Solutions President and Co-Founder.
To learn more about how elluminate provides life sciences companies with greater control of their clinical trial data, visit www.eclinicalsol.com.